Premier Clinical Research Institute

Miami, Florida 33122-1335

2 studies enrolling now · 14 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Depressive Disorder, Major, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, Endocrine System Diseases, Glomerulonephritis, Glomerulosclerosis, Focal Segmental, Kidney Diseases, Major Depressive Disorder, Nephritis

Studies at this site

• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Recruiting now
• A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia — Recruiting now
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) — Recruiting now
• A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine — Completed
• An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) — Completed
• A Study of JZP150 in Adults With Posttraumatic Stress Disorder — Completed
• Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations — Completed
• Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® — Stopped early
• This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia — Completed
• NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa — Completed
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
• Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease — Completed
• Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia — Completed
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed